CY1115306T1 - Συνθεσεις και χρησεις αυτων - Google Patents
Συνθεσεις και χρησεις αυτωνInfo
- Publication number
- CY1115306T1 CY1115306T1 CY20141100507T CY141100507T CY1115306T1 CY 1115306 T1 CY1115306 T1 CY 1115306T1 CY 20141100507 T CY20141100507 T CY 20141100507T CY 141100507 T CY141100507 T CY 141100507T CY 1115306 T1 CY1115306 T1 CY 1115306T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- subject
- compositions
- patients
- glycogenesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Περιγράφονται μέθοδοι για τον έλεγχο των επιπέδων γλυκόζης στον ορρό του αίματος σε ένα άτομο, με τις μεθόδους να περιλαμβάνουν το στάδιο της χορήγησης στο αναφερθέν άτομο μιας θεραπευτικής διατροφικής σύνθεσης που περιλαμβάνει ένα κηρώδες και/ή υδροθερμικά επεξεργασμένο άμυλο. Η μέθοδος μπορεί να χρησιμοποιηθεί για την αντιμετώπιση ή την πρόληψη της υπογλυκαιμίας σε ασθενείς ευάλωτους σε υπογλυκαιμικά επεισόδια, για παράδειγμα ασθενείς με γλυκογονίαση, διαβήτη ή ηπατοπάθεια. Η μέθοδος μπορεί επίσης να χρησιμοποιηθεί στη διατροφή των αθλητών. Περιγράφονται επίσης συνθέσεις για χρήση στις μεθόδους.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0325942.1A GB0325942D0 (en) | 2003-11-06 | 2003-11-06 | Compositions and uses thereof |
EP04798407.5A EP1680134B2 (en) | 2003-11-06 | 2004-11-08 | Compositions and uses therof |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115306T1 true CY1115306T1 (el) | 2017-01-04 |
Family
ID=29726075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100507T CY1115306T1 (el) | 2003-11-06 | 2014-07-07 | Συνθεσεις και χρησεις αυτων |
Country Status (17)
Country | Link |
---|---|
US (1) | US8507462B2 (el) |
EP (1) | EP1680134B2 (el) |
JP (1) | JP5248776B2 (el) |
CN (1) | CN1901922B (el) |
AU (1) | AU2004287263B2 (el) |
CA (1) | CA2544965C (el) |
CY (1) | CY1115306T1 (el) |
DK (1) | DK1680134T4 (el) |
ES (1) | ES2478565T5 (el) |
GB (1) | GB0325942D0 (el) |
HK (1) | HK1097754A1 (el) |
HR (1) | HRP20140660T4 (el) |
NZ (1) | NZ546987A (el) |
PL (1) | PL1680134T5 (el) |
PT (1) | PT1680134E (el) |
SI (1) | SI1680134T2 (el) |
WO (1) | WO2005044284A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0325942D0 (en) † | 2003-11-06 | 2003-12-10 | Glycologic Ltd | Compositions and uses thereof |
US8557274B2 (en) | 2005-12-06 | 2013-10-15 | Purdue Research Foundation | Slowly digesting starch and fermentable fiber |
US20110287131A1 (en) * | 2008-12-09 | 2011-11-24 | Shoba Murali | Heat moisture treated carbohydrates and uses thereof |
US9481777B2 (en) | 2012-03-30 | 2016-11-01 | The Procter & Gamble Company | Method of dewatering in a continuous high internal phase emulsion foam forming process |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1306384A (el) | 1969-05-05 | 1973-02-07 | ||
GB2026837A (en) * | 1978-07-31 | 1980-02-13 | Cpc International Inc | Starch containing food products |
WO1990015147A1 (en) † | 1989-06-06 | 1990-12-13 | Washington State University Research Foundation, Inc. | Purified resistant starch products and their preparation |
JP2996707B2 (ja) * | 1990-09-21 | 2000-01-11 | 三和興産株式会社 | 湿熱処理澱粉の効率的製造法 |
JPH06169680A (ja) * | 1992-12-09 | 1994-06-21 | Sanwa Kosan Kk | パン類およびパン粉の製造法 |
US5843921A (en) † | 1994-03-15 | 1998-12-01 | Childrens Hospital Of Los Angeles | Therapeutic food composition and method to diminish blood sugar fluctuations |
IL112967A0 (en) † | 1994-03-15 | 1995-06-29 | Los Angeles Childrens Hospital | Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
US5605893A (en) * | 1994-03-15 | 1997-02-25 | Children's Hospital Of Los Angeles | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients |
US5576048A (en) * | 1995-06-07 | 1996-11-19 | American Maize-Products Company | Foodstuffs containing a waxy waxy amylose extender starch |
JP2790610B2 (ja) * | 1994-07-21 | 1998-08-27 | ホクレン農業協同組合連合会 | α−グルコシダーゼ阻害剤、それを含む糖組成物、甘味料、食品、及び飼料 |
JPH09172961A (ja) * | 1995-12-22 | 1997-07-08 | Oyama Nyugyo Nogyo Kyodo Kumiai | ファットスプレッド様の発酵乳 |
JPH11130696A (ja) * | 1997-08-27 | 1999-05-18 | Takeda Chem Ind Ltd | 経口徐放性製剤 |
US6238708B1 (en) * | 1999-02-23 | 2001-05-29 | The Iams Company | Composition and process for controlling glucose metabolism in companion animals by dietary starch |
DE19911001C2 (de) * | 1999-03-12 | 2002-06-20 | Aventis Cropscience Gmbh | Verfahren zur Herstellung resistenter Stärke, resistente Stärke und deren Verwendung |
FR2791686A1 (fr) * | 1999-03-30 | 2000-10-06 | Ulice | Produits issus d'un ble a tres haute teneur en amylopectine et ses applications. |
US6733815B2 (en) * | 1999-04-16 | 2004-05-11 | Cargill, Incorporated | Food ingredient containing wheat gluten, soy grits and soy flour |
JP3113873B1 (ja) * | 1999-11-09 | 2000-12-04 | 株式会社日麺 | ゆで麺及びその製造法 |
AUPQ673300A0 (en) * | 2000-04-06 | 2000-05-04 | Penford Australia Limited | Starch sub-types and lipid metabolism |
EP1328280B1 (en) * | 2000-10-25 | 2006-08-02 | Metcon Medicin AB | Composition for the treatment of dysglucaemia and method for the production of said composition |
US6890571B2 (en) † | 2002-05-14 | 2005-05-10 | National Starch And Chemical Investment Holding Corporation | Slowly digestible starch product |
US7081261B2 (en) † | 2002-05-14 | 2006-07-25 | National Starch And Chemical Investment Holding Corporation | Resistant starch prepared by isoamylase debranching of low amylose starch |
GB0325942D0 (en) † | 2003-11-06 | 2003-12-10 | Glycologic Ltd | Compositions and uses thereof |
US20060025381A1 (en) † | 2004-07-29 | 2006-02-02 | National Starch And Chemical Investment Holding Company | Use of a chemically modified starch product |
-
2003
- 2003-11-06 GB GBGB0325942.1A patent/GB0325942D0/en not_active Ceased
-
2004
- 2004-11-08 JP JP2006538929A patent/JP5248776B2/ja active Active
- 2004-11-08 NZ NZ546987A patent/NZ546987A/en unknown
- 2004-11-08 AU AU2004287263A patent/AU2004287263B2/en active Active
- 2004-11-08 CA CA2544965A patent/CA2544965C/en active Active
- 2004-11-08 DK DK04798407.5T patent/DK1680134T4/en active
- 2004-11-08 PL PL04798407T patent/PL1680134T5/pl unknown
- 2004-11-08 ES ES04798407.5T patent/ES2478565T5/es active Active
- 2004-11-08 CN CN2004800399980A patent/CN1901922B/zh active Active
- 2004-11-08 PT PT47984075T patent/PT1680134E/pt unknown
- 2004-11-08 WO PCT/GB2004/004682 patent/WO2005044284A1/en active Application Filing
- 2004-11-08 EP EP04798407.5A patent/EP1680134B2/en active Active
- 2004-11-08 US US10/578,551 patent/US8507462B2/en active Active
- 2004-11-08 SI SI200432172T patent/SI1680134T2/en unknown
-
2007
- 2007-04-19 HK HK07104115.5A patent/HK1097754A1/xx unknown
-
2014
- 2014-07-07 CY CY20141100507T patent/CY1115306T1/el unknown
- 2014-07-11 HR HRP20140660TT patent/HRP20140660T4/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004287263B2 (en) | 2011-01-27 |
AU2004287263A1 (en) | 2005-05-19 |
DK1680134T3 (da) | 2014-07-14 |
JP5248776B2 (ja) | 2013-07-31 |
SI1680134T2 (en) | 2018-04-30 |
US8507462B2 (en) | 2013-08-13 |
US20070077277A1 (en) | 2007-04-05 |
CA2544965C (en) | 2013-10-29 |
EP1680134A1 (en) | 2006-07-19 |
CN1901922B (zh) | 2011-10-26 |
CA2544965A1 (en) | 2005-05-19 |
PL1680134T5 (pl) | 2018-06-29 |
DK1680134T4 (en) | 2018-04-23 |
ES2478565T3 (es) | 2014-07-22 |
HRP20140660T1 (en) | 2014-10-10 |
JP2007510704A (ja) | 2007-04-26 |
HRP20140660T4 (hr) | 2018-08-10 |
EP1680134B2 (en) | 2018-03-07 |
HK1097754A1 (en) | 2007-07-06 |
SI1680134T1 (sl) | 2014-09-30 |
CN1901922A (zh) | 2007-01-24 |
EP1680134B1 (en) | 2014-04-30 |
NZ546987A (en) | 2009-09-25 |
GB0325942D0 (en) | 2003-12-10 |
PT1680134E (pt) | 2014-07-16 |
ES2478565T5 (es) | 2018-04-17 |
WO2005044284A1 (en) | 2005-05-19 |
PL1680134T3 (pl) | 2014-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
da Luz et al. | Potential therapeutic effects of branched-chain amino acids supplementation on resistance exercise-based muscle damage in humans | |
CY1106771T1 (el) | Φαρμακευτικη συνθεση η οποια χρησιμοποιειται για τον ελεγχο της γλυκοζης του αιματος σε ασθενεις με διαβητη τυπου 2 | |
CY1115306T1 (el) | Συνθεσεις και χρησεις αυτων | |
EP2243383A3 (en) | A method and composition for nutritionally improving glucose control and insulin action | |
Nakano et al. | Effect of intensive salt‐restriction education on clinic, home, and ambulatory blood pressure levels in treated hypertensive patients during a 3‐month education period | |
WO2007128817A3 (en) | Insulin derivative | |
DE60331236D1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
NO20060498L (no) | Metode for a promotere benvekst | |
UA88257C2 (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ | |
EA200870088A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови | |
TW200633696A (en) | Sesamin/episesamin compositions | |
EA201001287A1 (ru) | Лечение гиперглицемии 25-гидроксивитамином d3 | |
DK1643861T3 (da) | Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter | |
Román et al. | Translating current knowledge into dementia prevention | |
NO20070996L (no) | Fremgangsmate for behandling av CCR2 medierte sykdommer eller lidelser | |
BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
Ma et al. | Long-term functional outcomes of vascularized fibular and iliac flap for mandibular reconstruction: A systematic review and meta-analysis | |
Ribeiro-Junior et al. | Mandibular angle fractures treated with a single miniplate without postoperative maxillomandibular fixation: A retrospective evaluation of 50 patients | |
EA200801305A1 (ru) | Применение циклетанина и других фуропиридинов для лечения гипертензии с преобладанием систолического давления, изолированной систолической гипертензии, повышенного пульсового артериального давления и общей гипертензии | |
NO20054096L (no) | Inhibitor for perioperativ blodsukkerforhoyelse | |
WO2022043273A3 (en) | Oral care composition comprising a fructanase | |
Burke | Nitric oxide and its role in health and diabetes | |
DE602005024147D1 (de) | Pharmazeutische zusammensetzungen zur linderung von übermässig hohen zuckerspiegeln bei diabetikern | |
DK1494746T3 (da) | Insulin til anvendelse i en dosering | |
Baggott et al. | Folic acid supplements are good (not bad) for rheumatoid arthritis patients treated with low-dose methotrexate |